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Reed M. Gardner, John L. Hankinson, and Blair J. West 
As a follow-up to the Snowbird Workshop on the Standardiza. 
tion of Spirometry, 35 manufacturers were invited to send 
spirometers for testing. From this invitation we received and 
tested 17 devices for com pi iance with the American Thoracic 
Society draft spirometer standards. There were two purposes 
in testing: ( 1) To determine if spirometers could be tested with 
the general test signals proposed in the standard. (2) To estab-
1 ish whether devices currently on the market would be able to 
meet the specifications or if the specifications were too str in-
gent and none of the devices would meet them. These results 
are not to be used by manufacturers as a certification by the 
American Thoracic Society, the federal government, or others 
that their device meets the American Thoracic Society specifi-
cations . 
Personal experience, literature review, and discussion at the 
Snowbird Workshop indicated that testing spirometers would 
be a difficult task. To make the testing as simple as possible we 
decided to test only the spirometer itself rather than entire 
systems. Because spirometers are generally used in systems, 
the systems will also need to be tested eventually. 
A mechanical stimulator of some kind is necessary to provide 
reproducible test signals because patients and even trained 
subjects have more variability than the 3 per cent error desired 
and because subjects are not readily available to simulate a 
variety of pathologic conditions. Therefore , the air moving 
syringe system designed by Novatek Inc. and constructed under 
an NIOSH contract was used. The air mover consists of a cylin· 
der and a piston, which gives a displacement proportional to 
applied input voltage with an accuracy of approximately ± 30 
mi. Accuracy measurements were determined by measuring 
the physical dimensions of the cylinder and monitoring the 
piston displacement as a function of applied input voltage. The 
linearity of this hydraulically driven system is limited only by 
the displacement transducer, which measures actual piston dis· 
placement for use in the feedback control system. A digital 
computer was then programmed to generate the waveforms 
out! ined in table 1. The air moving system was connected to 
the computer through a 12-bit digital -analog converter. Test 
signals 1 through 12 are exponential signals generated mathe· 
matically by the computer with the volumes and time constants 
indicated. Signals 13 through 16 are for human subject data, 
which were digitized from an analog tape recording of actual 
patient data from the volume spirometer. These final 4 test 
signals are representative of a varity of patient types, and the 
"artifact" in the human data provided a more realistic testing 
signal . Tests 15 and 16 obtained from obstructed patients were 
especially demanding and actually exceeded the requirements 
of the ATS draft standards. One of the tests required an expira· 
tion time of 17 sec . In fairness to the manufacturers whose 
devices were tested and in the spirit of investigative science, it 
must be stated that the testing methods and signals are not 
perfect; however, they were uniformly applied to each device. 
Preliminary results are shown in table 2, which shows results 
of forced vital capacity (FVC) testing . Specifically reported 
are resistance, FVC and 1-sec forced expiratory volume. Not 
reported are instantaneous flow and results from maximal 
voluntary ventilation testing . Of the devices tested, 8 met the ~ 
*Supported in part by NH LBI Contract No . 1-HR-5·3028 (Standardi· 
zation in Epidemiological Studies). . 
Testing of spirometers was possible through the courtesy and generositY 
of N IOSH Appalachian Laboratory at Morgantown , W.V . 
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Ti 
Volume Con 
Test (ml) (st 
1 6,000 0 
2 6 ,000 0 
3 6,000 2 
4 5,000 0. 
5 5 ,000 0. 
6 5,000 2. 
7 3,500 0. 
8 3 ,500 0. 
9 3,500 2. 
10 1,500 0. 
11 1,500 0. 
12 1,500 2. 
13 4,638 Normal P< 
14 5,188 Normal p; 
15 2,675 Obstructe 
16 5,613 Obstructe 
•1-sec forced expiratory vol t 
TABLE 2 
·------------ Preliminary Findings of Spirometer Testing* 
specifications for FVC, 2 were borderline, and 7 did not meet 
' the specifications. We invited manufacturers to retest their 
instruments if they had not met the specifications. Some of 
the manufacturers took this opportunity. As a result of this 
retest, some devices moved from the "no" category to the 
"yes" category . 
The preliminary results presented in table 2 show that ( 1) the 
ATS specifications are reasonable and can be met by many 
current sp irometers ; (2) testing of spirometers can be carried 
1 out to the accuracy needed to verify that the instrument meets 
ATS specifications . Note that most volume measurement in-
struments had I ittle d ifficulty meeting the ATS specifications, 
which are in this case the volume specifications, whereas most 
flow-measuring devices had difficulty. It is possible that the 
How-measuring devices would have outperformed the volume 
devices if flow measurements had been carefully tested . The 
question of how to test for flow characteristics and resolve the 
complex, dynamic characteristics of flow signals requires further 
study. 
Miscellaneous Observations during Testing 
The problems of temperature and humidity and their effect 
on the results are extremely important with all of the devices. 
For the volume-measuring device, temperature measurement 
and equilibration together with compensation for water vapor 
is extremely important. Based on the testing results , we recom-
mend that every sp irometer be equ ipped with a thermometer. 
The subtle differences in testing of dry versus wet spirometers 
within room air can cause errors of 1 to 2 per cent. Testing 
with heated and humidif ied air dr iven into a volume spirometer 
indicated time constants varying from 4 and one-half sec to 15 
sec and volume errors of approximately 80 ml in a simulated 6-
liter forced expiration. The shorter time constants were with 
longer interconnecting tubing and the longer time constants 
were with shorter interconnecting tubing , indicating that the 
most rapid heat loss is in the tubing. 
Flow sensors that are both temperature and humidity sensitive 
were especially difficult to test and evaluate. These problems 
are also man ife sted in clinical situations where patients may 
not be at 37° C but may be 38 or 36° C. 
TABLE 1 
Forced Vital Capacity (FVC) Testing Signals 
Values 
Time Calculated FEVIf 
Volume Constan t Peak Flow FEv,• FVC 
Test (m l) (sec) (/iter/sec) (ml) (%) 
1 6 ,000 0.4 15.00 5,507 91 .8 
2 6 ,000 0 .8 7.50 4 ,281 71.4 
3 6 ,000 2.4 2.50 2,045 34.1 
4 5,000 0.4 12.50 4,590 91 .8 
5 5,000 0.8 6 .25 3,567 71 .4 
6 5,000 2.4 2.08 1,704 34.1 
7 3,500 0.4 8.75 3 ,213 91 .8 
8 3,500 0.8 4.38 2.497 71 .3 
9 3,500 2.4 1.46 1,193 34.1 
10 1,500 0.4 3 .75 1,377 91 .8 
11 1,500 0.8 1.88 1,070 71.3 
12 1,500 2.4 0.63 511 34.1 
13 4,638 Normal patient 3,788 81 .7 
14 5,188 Normal patient 4 ,075 78.5 
15 2,675 Obstructed pa t ient 1,300 48.6 
16 5 ,613 Obstru cted patient 3 ,413 60.8 
*1 -sec forced expiratory volume . 
Meets Resistance 
ATS em H20 FVC 
FVC, l i ter/sec @ Max imal FEV1 
Device FEV1 120/i ter/ Error Max imal Er ror 
No. Type Specs sec) ( %) ( %) 
1 Volume Yes 0 .72 1.2 1.8 
2 Volume Yes 0.54 1.5 1.4 
3 Volume Yes 0.70 1.5 2.6 
4 Volume Yes 0.92 1. 7 2.7 
5 Volume Yes 0 .64 2.6 2.4 
6 Volume Yes? 7 1.84 1.7 4 .5 
7 Volume Yes 0 .50 1.0 2.2 
8 Volume Yes? 1.16 3 - 4 
9 Volume No 0.92 6.2 11 .6 
10 Volume No 2.4 10 15 
11 Flow No 1.04 - 10 - 10 
12 Flow Yes 1.20 3 3 
13 Flow No 0.60 - 10 - 7 
14 Flow Yes 0.35 - 3 3 
15 Flow No 0.16 6.2 - 29 3.8- 10.3 
16 Flow No 0 .20 o- 7.7 o- 5.7 




Definition of abbreviations : FVC ; f orced vi tal capacity ; FEV1 ; 
1 _..ec forced ex piratory volume . 
• Results are reported in abbreviated fo rm because for each device at 
least 16 tests were run. Max imal errors are indicated in most cases, but 
in some cases ranges of error are given to show var iabi lity . Because 
test ing and measurem ent errors may result f rom our errors we have 
given the device the benefi t o f the doubt in some cases. 
I UA T Invites Abstracts 
The International Union Against Tuberculosis (IUAT) invites 
those interested in presenting papers at its XXIV Conference 
in Brussels, Belgium, September 3 -9, 1978, to submit abstracts 
of their proposed presentations. 
The Conference will include four themes. The first theme, 
tuberculosis, includes these topics : ( 1) Epidemiology, natural 
history , surveillance ; (2) Immunology and bacteriology : Case 
finding and diagnostic methods ; (3) Chemotherapy : Controlled 
clinical trails ; (4) Prevention : Chemoprophylaxis and BCG; (5) 
Socio-economic aspects . 
The second theme covers these topics : ( 1) Chronic obstructive 
lung disease : (bronchitis , emphysema, asthma) ; (2) Lung fibro-
sis; (3) Pathogenes is and pathophysiology ; (4) Environmental 
factors : tobacco, smoking, air pollution , occupational exposure ; 
(5) Host factors: Lung defense mechanisms , genetics ; (6) 
Screening tests and new diagnostic methods ; (7) Treatment 
and rehabilitation ; (8) Prevention : Public health and commun-
ity aspects . 
Leprosy is the th ird theme ; the topics are epidemiology, 
chemotherapy , and combined programs for tuberculosis, 
leprosy, and other diseases. The fourth theme is primary health 
care-promotion of health, tra ining. 
I UAT requests you to write your abstract in English or French, 
lim iting it to 300 words and submit five copies in time for 
arrival September 30, 1977. Send abstracts to International 
Union Against Tuberculosis, 3 Rue Georges Ville, 75 116 Paris, 
France _ 
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